Because the role of RUNX1T1 by itself as a nonfusion protein has rarely been examined in cancer, including lung carcinoma, we sought to determine whether RUNX1T1 could contribute to the SCLC phenotype and if so, its mechanism of action. Here, RUNX1T1 is linked to lung carcinoma.